Answers are grounded in this paper and cite their sources.
While skin injuries and chronic wounds impose a serious global health and socio-economic burden, silk proteins (silk fibroin and silk sericin) present a prominent alternative due to their high biocompatibility, low inflammatory potential, and regenerative properties. In this study, a descriptive bibliometric analysis was conducted to evaluate the global scientific progress, knowledge structure, thematic transformation, and international collaboration networks of silk protein-based wound healing research between 1999 and 2026. Conducted in accordance with the principles of the BIBLIO guidelines, the data were retrieved from the Web of Science Core Collection (WoSCC) on 30 July 2026, and 1347 publications meeting the inclusion criteria were subjected to performance and science mapping analyses using R software (version RVER; Bibliometrix 4.6.1/Biblioshiny 5.0). Findings indicate that annual publication productivity gained significant momentum after 2020, reaching its highest complete-year value in 2024 (207 publications); a logistic life-cycle model fitted to complete years placed the inflection point around 2030, indicating that the field is still growing rather than approaching saturation. The International Journal of Biological Macromolecules (147 publications) was identified as the most productive journal, P. Aramwit (Chulalongkorn University, Thailand; 32 publications) as the most productive author, and the 2004 study by B. M. Min et al. (1004 citations) as the most impactful publication. China contributed to the largest number of publications (586), followed by India, the USA, and Iran. Where the silk source was reported, Bombyx mori silk predominated, whereas wild silkworm, spider, and recombinant silks remained marginal. Thematic evolution analyses reveal that the research focus has shifted from traditional scaffolds and electrospinning techniques toward smart hydrogels, diabetic wound care, angiogenesis, and photothermal therapy, with exosome delivery systems emerging recently, while silk sericin forms a stable but specialised research niche. Human clinical studies accounted for less than 1% of the corpus; future studies should therefore focus on standardised reporting of silk sources, global purification standards, and adequately powered human clinical trials.
No takes yet. Share an insight, caveat, or question.
Yılmaz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: